Who Regulates Research Materials: Argentina

ANMAT, the Argentine Customs Directorate, and SEDRONAR are the three principal bodies that intervene when research materials are imported or handled in Argentina. ANMAT steps in when a material falls under the definition of a medicine or diagnostic reagent. Customs classifies every product arriving from abroad and enforces whatever prior permits those agencies require. SEDRONAR supervises when a compound is listed as a chemical precursor or controlled substance. Understanding what each agency governs — and what it does not — determines what documentation to prepare before a shipment is ordered.

ANMAT: Medicines, Devices, and Health Products

Argentina's Administración Nacional de Medicamentos, Alimentos y Tecnología Médica (ANMAT) is the technical-scientific body under the Ministry of Health responsible for authorizing the registration, manufacture, import, and commercialization of medicines, cosmetics, diagnostic reagents, and medical devices.

A critical point for anyone working with research materials: ANMAT does not directly regulate laboratory reagents that are not destined for human consumption or diagnostic use. The boundary is narrow, however. If a compound is presented as a medicine, carries therapeutic indications, or enters the country under a pharmaceutical denomination, ANMAT has complete jurisdiction and requires a registration certificate before import can clear.

For materials strictly categorized as Research Use Only (RUO) — exclusive use in laboratory research — the decisive factor is the accompanying documentation: clear labeling as a laboratory reagent, no indications of use in people or animals, and an appropriate Safety Data Sheet (SDS).

ANMAT also regulates clinical trials in Argentina through DECAP, the Department of Clinical Trials and Product Approvals. DECAP requires prior approval before any compound is administered to a human being within a research protocol. That is a distinct track from working with the same compound under in vitro laboratory conditions, which falls outside that approval circuit entirely.

Argentine Customs: The First Control on Entry

Every material arriving in Argentina from abroad passes through the Dirección General de Aduanas (DGA), which operates under the Federal Administration of Public Revenue (AFIP). Customs classifies products according to the Nomenclatura Común del MERCOSUR (NCM), a harmonized system that determines tariffs, restrictions, and requirements for each category of goods.

Chemically synthesized peptides imported as research reagents are typically classified under NCM Chapter 29 (organic chemical products) or Chapter 35 (albuminoid substances, glues, and enzymes), depending on composition and how the customs classifier resolves the product. Each NCM code carries associated import duties, VAT, potential AFIP surcharges, and — most importantly — any prior permits that other agencies may require.

When a product requires ANMAT intervention before entry — for example, if it is a registered medicine or diagnostic reagent — the importer must present ANMAT documentation to customs before the shipment is released. If the material is classified as a research chemical reagent without health applications, the customs process follows the standard circuit for chemical products.

The documentation the supplier generates has direct weight in this process. A certificate of analysis (COA) issued by an independent laboratory, the Safety Data Sheet (SDS), and RUO labeling are the three documents that most determine how customs classifies and processes the entry. PeptoClinic supplies research peptides to destinations in Argentina with the customs file prepared for import as laboratory reference material: the details of that process are on the shipping page.

SEDRONAR: Precursors and Controlled Substances

The Secretaría de Políticas Integrales sobre Drogas de la Nación Argentina (SEDRONAR) administers Argentina's list of chemical precursors and controlled substances, coordinated with the International Narcotics Control Board (INCB). Any company or laboratory that imports, exports, manufactures, stores, or uses these compounds must register in SEDRONAR's operator registry and declare each transaction.

Most research peptides — including BPC-157 and retatrutide — are not on SEDRONAR's controlled precursor lists. The situation can change if a compound shares chemical structure with a controlled substance or if a subsequent resolution adds it to the list. Checking the current SEDRONAR list before each import operation is part of routine compliance, not a one-time confirmation.

The Ministry of Science and CONICET

Argentina's Ministerio de Ciencia, Tecnología e Innovación sets general policy for scientific activity in the country. CONICET, the National Scientific and Technical Research Council, is a decentralized body under that ministry and the country's principal research funding and evaluation body.

CONICET and national universities have their own ethics and biosafety committees that review research protocols involving biologically active substances. When a researcher works with peptides under a CONICET project, those committees evaluate the protocol's risks, storage and handling procedures, and material traceability.

This institutional layer of oversight coexists with federal regulatory controls: customs governs entry, ANMAT intervenes if the material carries a pharmaceutical character, and institutional committees govern the use protocol inside the laboratory. The three layers are independent and can act simultaneously.

How These Bodies Interact in Practice

For a laboratory importing synthesized peptides as reference materials or research reagents, regulatory intervention flows as follows:

• The external supplier generates lot documentation: COA, SDS, and RUO labeling. The quality of that documentation determines how customs and other agencies process the material. PeptoClinic's analysis reports are publicly available.
• Customs classifies the material under the NCM, collects applicable tariffs, and verifies that no prior ANMAT or SEDRONAR permits are outstanding.
• ANMAT intervenes only if the material requires prior registration — this applies to medicines, diagnostic reagents, and medical devices, not to chemically synthesized reagents for exclusive laboratory use.
• SEDRONAR intervenes only if the compound appears on the precursor or controlled substances list.
• The institutional ethics committee reviews the research protocol within the laboratory or institution that will use the material.

All four levels can act in parallel or in sequence, depending on the compound's nature and intended use. The documentation a supplier provides is the thread connecting all those controls.

For Laboratory Research Only

PeptoClinic supplies research peptides strictly for in vitro laboratory use. No material in the PeptoClinic catalogue is approved or indicated for human or veterinary use. PeptoClinic is not a pharmacy, not a clinic, and does not issue or fill prescriptions. Requests for human administration protocols are declined without exception.

Researchers working with these materials in Argentina must operate within an institutional framework that includes an approved ethics committee, facilities appropriate for handling chemical reagents, and permits from whichever agencies apply based on the compound's classification. Information on how PeptoClinic prepares shipments for Argentine research destinations is available on the site.